
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast
00:00
Managing Primary Refractory DLBCL
This chapter examines the evaluation and treatment strategies for patients with primary refractory diffuse large B-cell lymphoma (DLBCL). It highlights the significance of patient assessment for curative therapies like CAR-T and looks at various chemotherapy regimens and their response rates. The discussion also addresses the historical context of treatments, the current landscape of CAR-T therapies, and the challenges in managing patient care effectively.
Transcript
Play full episode